Literature DB >> 9595560

Evidence for a load receptor contribution to the control of posture and locomotion.

V Dietz1.   

Abstract

A basic aspect of the neuronal control of bipedal stance and gait represents the antigravity function of leg extensors. Proprioceptive reflexes involved in the maintenance of body equilibrium depend on the presence of contact forces opposing gravity. Extensor load receptors are thought to signal changes of the projection of the body's centre of mass with respect to the feet. According to recent observations in the spinal cat, this afferent input probably arises from Golgi tendon organs and represents a newly discovered function of these receptors in the regulation of stance and gait. In humans, evidence for a significant contribution of the load receptor to leg muscle activation has come from immersion experiments. Compensatory leg muscle activation depends on the actual body weight. Furthermore, recent experiments in paraplegic patients showed that the beneficial effects of a locomotor training critically depends on the initial degree of body unloading and reloading during the course of the training period.

Entities:  

Mesh:

Year:  1998        PMID: 9595560     DOI: 10.1016/s0149-7634(97)00035-3

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  21 in total

1.  Characterisation of the quadriceps stretch reflex during the transition from swing to stance phase of human walking.

Authors:  N Mrachacz-Kersting; B A Lavoie; J B Andersen; T Sinkjaer
Journal:  Exp Brain Res       Date:  2004-06-25       Impact factor: 1.972

2.  Postural adjustments due to external perturbations during sitting in 1-month-old infants: evidence for the innate origin of direction specificity.

Authors:  Asa Hedberg; Hans Forssberg; Mijna Hadders-Algra
Journal:  Exp Brain Res       Date:  2004-03-13       Impact factor: 1.972

3.  Soleus H-reflex modulation during body weight support treadmill walking in spinal cord intact and injured subjects.

Authors:  Maria Knikou; Claudia A Angeli; Christie K Ferreira; Susan J Harkema
Journal:  Exp Brain Res       Date:  2008-11-15       Impact factor: 1.972

4.  Sensorimotor integration of vision and proprioception for obstacle crossing in ambulatory individuals with spinal cord injury.

Authors:  Raza Naseem Malik; Rachel Cote; Tania Lam
Journal:  J Neurophysiol       Date:  2016-10-12       Impact factor: 2.714

5.  Bilateral Proprioceptive Evaluation in Individuals With Unilateral Chronic Ankle Instability.

Authors:  Andreia S P Sousa; João Leite; Bianca Costa; Rubim Santos
Journal:  J Athl Train       Date:  2017-03-20       Impact factor: 2.860

6.  Short and Medium Latency Responses in Participants With Chronic Ankle Instability.

Authors:  Andreia S P Sousa; Isabel Valente; Ana Pinto; Tiago Soutelo; Márcia Silva
Journal:  J Athl Train       Date:  2018-08-10       Impact factor: 2.860

7.  Alteration of H-reflex amplitude modulation is a marker of impaired postural responses in individuals with incomplete spinal cord injury.

Authors:  Charlotte H Pion; Mélissa St-Pierre Bolduc; Zoé Miranda; Maureen MacMahon; Dorothy Barthélemy
Journal:  Exp Brain Res       Date:  2021-03-31       Impact factor: 1.972

8.  Acquisition of a simple motor skill: task-dependent adaptation and long-term changes in the human soleus stretch reflex.

Authors:  N Mrachacz-Kersting; U G Kersting; P de Brito Silva; Y Makihara; L Arendt-Nielsen; T Sinkjær; A K Thompson
Journal:  J Neurophysiol       Date:  2019-06-05       Impact factor: 2.714

9.  Group II muscle afferents probably contribute to the medium latency soleus stretch reflex during walking in humans.

Authors:  M J Grey; M Ladouceur; J B Andersen; J B Nielsen; T Sinkjaer
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

10.  Differential integration of visual and kinaesthetic signals to upright stance.

Authors:  Brice Isableu; Benoît Fourre; Nicolas Vuillerme; Guillaume Giraudet; Michel-Ange Amorim
Journal:  Exp Brain Res       Date:  2011-04-28       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.